These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6407253)

  • 1. A study of thyroid function after subtotal thyroidectomy for Graves' disease: particularly on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients.
    Fukino O; Tamai H; Fujii S; Ohsako N; Matsubayashi S; Kuma K; Nagataki S
    Acta Endocrinol (Copenh); 1983 May; 103(1):28-33. PubMed ID: 6407253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients.
    Tamai H; Ohsako N; Takeno K; Fukino O; Takahashi H; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1123-7. PubMed ID: 6774999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of thyroid function in patients with Graves' disease after 5 to 10 years of subtotal thyroidectomy: with special emphasis on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients (author's transl)].
    Fukino O; Tamai H; Mori K; Ohsako N; Takeno K; Esaki M; Matsuzuka F; Kuma K; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1581-90. PubMed ID: 6799335
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease.
    Tamai H; Suematsu H; Ikemi Y; Kuma K; Matsuzuka F; Kumagai LF; Shizume K; Nagataki S
    J Clin Endocrinol Metab; 1978 Sep; 47(3):475-9. PubMed ID: 122407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function and histology in forty-five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment.
    Hirota Y; Tamai H; Hayashi Y; Matsubayashi S; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):165-9. PubMed ID: 2415549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
    Haug E; Frey HM; Sand T
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):335-44. PubMed ID: 405834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the TRH test on the patients with Graves' disease during the treatment with antithyroid drug (author's transl)].
    Enomoto K; Inoue K; Enomoto H
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1052-64. PubMed ID: 823053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
    Horimoto M; Nishikawa M; Uno C; Yoshikawa N; Taniguchi N; Inada M
    Endocrinol Jpn; 1988 Dec; 35(6):841-8. PubMed ID: 2471633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thyroidal response to thyrotropin-releasing hormone (TRH) as a predictive test of remission in euthyroid patients with Graves' disease].
    Takahashi H
    Fukuoka Igaku Zasshi; 1984 May; 75(5):241-51. PubMed ID: 6436156
    [No Abstract]   [Full Text] [Related]  

  • 17. Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy.
    Yamada T; Takasu N; Sato A; Aizawa T; Koizumi Y
    J Clin Endocrinol Metab; 1982 Jan; 54(1):83-8. PubMed ID: 6798061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in circulating thyroid hormones and thyrotropin in euthyroid patients with Graves' disease after total thyroidectomy: comparison between responders and nonresponders to TSH-releasing hormone.
    Tamai H; Mori K; Matsubayashi S; Hirota Y; Kobayashi A; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
    Metabolism; 1985 Nov; 34(11):1024-8. PubMed ID: 3932818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.